Parallel18
Parallel18 is a Puerto Rico-based startup accelerator and investment platform operating P18, BioLeap, Xpand, and VCAP programs. It supports early-stage international and local startups with funding, mentorship, and corporate connections, having supported over 600 startups since 2015.
- Company typePrivate
- Founded2015
- HeadquartersSan Juan, Puerto Rico
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Parallel18 does
Parallel18 is a Puerto Rico-based international startup accelerator and investment platform founded in 2015 and operated by the Puerto Rico Science, Technology and Research Trust, a private non-profit. It serves early-stage startups from Puerto Rico and international markets, providing funding, mentorship, business training, and investor and corporate connections. The organization has supported over 600 startups cumulatively and distributed $13.3M in seed capital.
The platform operates four core programs targeting distinct stages and verticals: P18, the flagship international acceleration program offering $100K SAFE investments in a 16-week cohort; BioLeap, a life sciences incubation program providing lab access at The Confluence Center; Xpand, a growth-stage community program for Puerto Rican companies with $250K+ revenue, subsidized by Banco Popular; and VCAP, a venture capital access program deploying $150K-$2.5M equity co-investments backed by a $30M SSBCI allocation. Supporting programs include the Matching Fund for follow-on capital and the Connect Program for corporate-startup introductions.
In 2026, after ten years as a grant-based accelerator, Parallel18 executed a strategic transition to a structured investment platform, replacing non-dilutive grants with SAFE investments and expanding its capital deployment range via VCAP. The business model is hybrid: grant funding from PRSTRT and public programs covers operations, corporate partnerships (Banco Popular) subsidize specific programs, and long-term returns on equity stakes in portfolio companies provide a sustainable capital recycling mechanism. Revenue is not publicly disclosed, consistent with its non-profit structure and public-mission mandate.
Parallel18 firmographics
Firmographics- Name
- Parallel18
- Legal name
- Parallel18 (Puerto Rico Science, Technology, and Research Trust)
- Website
- https://parallel18.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Parallel18 is a Puerto Rico-based startup accelerator and investment platform operating P18, BioLeap, Xpand, and VCAP programs. It supports early-stage international and local startups with funding, mentorship, and corporate connections, having supported over 600 startups since 2015.
- Ownership category
- akta.pro rank
Parallel18 industry classification
Industry- Product category
- Startup Acceleration & Investment
- NAICS
- Funds, Trusts, and Other Financial Vehicles (525), Portfolio Management and Investment Advice (523940)
- SIC
- Finance Services (6199), Federal & Federally-Sponsored Credit Agencies (6111)
- akta.pro primary industry
- Accelerators & Incubators (Investor-Operated) (FSANAAAM)
- akta.pro secondary industries
- Corporate Accelerators & Startup Programs (FSANAHAD), Development Finance & Blended Finance Facilities (BPADAOAD)
Keywords
Where Parallel18 is headquartered
LocationHeadquarters
- HQ city
- San Juan
- HQ country
- Puerto Rico
- HQ region
- Latin America
Offices1 record
Markets served
Parallel18 business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Investment Returns (SAFEs and Equity): Parallel18 invests in startups via Simple Agreements for Future Equity (SAFEs) and equity positions. P18 invests $100K per startup; VCAP invests $150K-$2.5M per company. Returns are generated when portfolio companies succeed through exits, acquisitions, or continued growth, creating a sustainable capital cycle for supporting future entrepreneurs.
- Grant Funding (Puerto Rico Science, Technology and Research Trust): The program is funded by the Puerto Rico Science, Technology, and Research Trust, a private non-profit organization. Funding supports operational costs and direct investments in startups. Xpand is subsidized by Banco Popular.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | One time/ perpetual license | P18 Acceleration Program - $100K Investment |
| Freemium | Pay-as-you-go | BioLeap Life Sciences Incubation - Free |
| Freemium | Pay-as-you-go | Xpand Growth Stage Program - Free |
| Other | One time/ perpetual license | VCAP Investment Program - $150K to $2.5M |
Go-to-market motion3 records
Distribution channels6 records
Marketing channels8 records
Parallel18 product offering
Product offeringCore offering
Parallel18 is a startup accelerator and investment platform that operates multiple programs (P18 international acceleration, BioLeap life sciences incubation, Xpand growth-stage program, and VCAP venture capital access) offering early-stage and growth-stage startups seed/SAFE investments, mentorship, business training, corporate introductions, and investor networking. It is a program of the Puerto Rico Science, Technology and Research Trust and supports startups with capital ranging from $100K SAFE investments up to $2.5M equity rounds.
Product overview
Parallel18 is a multi-program startup investment platform operated by the Puerto Rico Science, Technology and Research Trust. The platform consists of four core programs: P18 (international acceleration), BioLeap (life sciences incubation), Xpand (growth-stage community), and VCAP (venture capital access). These programs are designed to support startups at different stages—from early-stage international founders (P18) to Puerto Rican life science researchers (BioLeap) to established local companies seeking to scale (Xpand)—with investment capital, mentorship, and corporate connectivity. The platform also includes a Matching Fund for follow-on investments and a Connect Program for corporate-startup partnerships. The overall architecture supports startups from pre-acceleration through growth stage, creating a comprehensive ecosystem for building globally competitive companies from Puerto Rico.
Differentiator
Problem solved
Functional benefit
Brands
- P18: International startup acceleration program offering $100K investment via SAFE for early-stage startups from around the world, operating from Puerto Rico.
- BioLeap
- Xpand
- VCAP
- Parallel18 Ventures
Products and services
- P18 Acceleration Program International startup acceleration program investing $100K via SAFE in early-stage startups (3 years or less operations). 16-week curriculum including bootcamps, mentorship, weekly KPI follow-ups, investment immersion, and Demo Day. Targets startups incorporated in Puerto Rico or the US that relocate to Puerto Rico for the program duration.
- BioLeap Life Sciences Incubation Life sciences incubation program with 12-week curriculum plus 14-week technical assistance period. Drives scientific research and innovation toward commercialization in biotechnology, agrotech, medtech, bioengineering, medical devices, and digital health. Includes access to The Confluence Center fully equipped laboratory in Science City. All services are free to participants.
- Xpand Growth-Stage Program Growth-stage community program subsidized by Banco Popular. Supports Puerto Rican companies with 3+ years of operations and $250K+ annual sales with free resources including bootcamps, investment readiness assessment, technical assistance, roundtable meetings, and networking. Applications open year-round.
- VCAP (Venture Capital Access Program) Direct equity co-investment mechanism deploying SSBCI funds. Invests $150K to $2.5M in Pre-Seed, Seed, and Series A rounds of Puerto Rican companies, providing up to 50% of any given round with 1:1 matching from private investors. Focus sectors include Biopharmaceuticals, FinTech, Energy, Manufacturing, DeepTech, AI, and Travel & Tourism.
- Parallel18 Ventures Matching Fund Follow-on capital program that co-invests alongside private investors in top parallel18 alumni. Identifies startups with highest global scale potential and provides additional capital support beyond the initial program investment. The Matching Fund has supported multiple portfolio companies with $858,000 raised by alumni.
- Parallel18 Connect Corporate Partnership Program
Quantifiable outcome
- 320 companies graduated from P18 with 41.3% being Puerto Rican
- +3 more outcomes
Companies that use Parallel18
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles5 records
Parallel18 technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Parallel18 partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core, major and minor.
- Puerto Rico Science, Technology and Research TrustcoreParent organization that created and funds parallel18. A private non-profit created to maximize Puerto Rico's participation in the global knowledge economy by promoting investment and financing of science and technology research development. Manages over a dozen initiatives including grants, technical support, meetups, and educational resources.
- Corporate Partners (multiple)majorLong-term strategic collaborations with key players in the startup ecosystem. Partners include multiple corporations across industries that participate in industry meetups, provide seed capital, and engage in business development with startups through the Connect program. Multiple logos displayed indicating active corporate partnerships.
- The Confluence CenterminorFully equipped laboratory facility located in the Forward Building (parallel18 headquarters) in Science City. Provides BioLeap participants with dedicated space and specialized instruments for running experiments.
Scale indicators18 records
Recent moves7 records
Expansion highlights6 records
Parallel18 competitors and assessment
Company assessmentDirect peers
- IndieBio: Life sciences accelerator program operated by SOSV with intensive cohort-based biotech commercialization support. The closest direct comparable to Parallel18's BioLeap vertical.
- MassChallenge: Global nonprofit startup accelerator with similar mission of supporting early-stage founders across multiple verticals through mentorship, corporate partnerships, and equity-free programs. Most directly comparable on nonprofit, multi-program, international accelerator model.
- Techstars: Large global accelerator network with mentorship-driven 3-month cohorts and accelerator-week demo days. Comparable as a multi-stage venture support platform with corporate partner integration.
- SOSV: Multi-stage venture capital fund operating vertical-specific accelerator programs (including IndieBio for biotech — directly relevant to Parallel18's BioLeap program) with similar cohort-based investment model.
- Start-Up Chile: Government-backed startup accelerator program based in Chile providing equity-free funding to international founders. Highly comparable as a state-sponsored, international-focused, non-dilutive or low-dilution accelerator.
- Plug and Play: Global innovation platform combining accelerator programs with corporate venture and startup-corporate matchmaking (similar to Parallel18 Connect). Operates industry-specific verticals with international presence.
- BioGenerator: Nonprofit life sciences investor and accelerator supporting biotech startups from lab to commercialization, including laboratory access. Comparable to Parallel18's BioLeap program in mission, lab-enabled incubation, and nonprofit life sciences venture model.
- Y Combinator: Benchmark startup accelerator offering standardized SAFE-based investment in batches with demo day. The reference point for Parallel18's pivot to SAFE-based equity investment in P18.
- 500 Global (500 Startups): Global venture firm and accelerator operating programs across emerging markets including Latin America. Direct peer given international cohort model and early-stage equity investment approach.
Regional players
- Wayra (Telefónica): Corporate-backed startup accelerator operating across Latin America and Europe with equity investment and corporate partnership focus. Comparable as a regional LATAM accelerator with similar bridge-market positioning.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Parallel18 social profiles
Digital presenceParallel18 financial estimates
Financial estimateRevenue estimate
Valuation estimate
Parallel18 leadership team
Management profileNumber of profiles
Profiles15 records
Parallel18 subsidiaries and ownership
Company hierarchySubsidiaries4 records
Parallel18 funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Parallel18 M&A and investment
M&A and investmentM&A
Investments162 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Parallel18
What does Parallel18 do?
Parallel18 is a startup accelerator and investment platform that operates multiple programs (P18 international acceleration, BioLeap life sciences incubation, Xpand growth-stage program, and VCAP venture capital access) offering early-stage and growth-stage startups seed/SAFE investments, mentorship, business training, corporate introductions, and investor networking. It is a program of the Puerto Rico Science, Technology and Research Trust and supports startups with capital ranging from $100K SAFE investments up to $2.5M equity rounds.
Is Parallel18 a public or private company?
Parallel18 is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Parallel18 founded?
Parallel18 was founded in 2015. It employs 11 to 50 people.
Where is Parallel18 based?
Parallel18 is headquartered in San Juan, Puerto Rico, in the Latin America region.
How does Parallel18 make money?
Two revenue lines are on record. Investment Returns (SAFEs and Equity) is the primary driver. The others are grant Funding (Puerto Rico Science, Technology and Research Trust).
Who are Parallel18's main competitors?
Direct peers on record are IndieBio, MassChallenge, Techstars, SOSV, Start-Up Chile, Plug and Play, BioGenerator, Y Combinator and 500 Global (500 Startups). Wayra (Telefónica) is listed as a regional player.
Does Parallel18 have an API?
No public API is recorded for Parallel18.
What industry is Parallel18 in?
Parallel18's product category is Startup Acceleration & Investment. Its primary akta.pro industry code is FSANAAAM, Accelerators & Incubators (Investor-Operated), with a secondary code of FSANAHAD, Corporate Accelerators & Startup Programs. Its NAICS code is 525 and its SIC code is 6199.